Cargando…
Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
Numerous studies have demonstrated the clinical activity of temozolomide, a second-generation alkylating agent, against malignant brain tumors, however, its activity has not been reported in an Asian population. This study analyzed the efficacy and toxicity of temozolomide in 25 adult patients with...
Autores principales: | Yang, Seung-Ho, Kim, Moon-Kyu, Lee, Tae-Kyu, Lee, Kwan-Sung, Jeun, Sin-Soo, Park, Chun-Kun, Kang, Joon-Ki, Kim, Moon-Chan, Hong, Yong-Kil |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729901/ https://www.ncbi.nlm.nih.gov/pubmed/16891823 http://dx.doi.org/10.3346/jkms.2006.21.4.739 |
Ejemplares similares
-
Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma
por: Woo, Jong-Yun, et al.
Publicado: (2015) -
Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma
por: Ahn, Stephen, et al.
Publicado: (2022) -
Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
por: Park, Jae-Hyun, et al.
Publicado: (2015) -
Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010) -
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013)